Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001209191-23-037613 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.08 | -20.7K | 1.70M | -1% | -$332.9K |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +20.7K | 1.71M | +1% | +$46.6K |
| DM | 2023-06-15 | 2023-06-13+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $0.00 | -20.7K | 376.8K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-13 | S | D | 7,927 | $16.00 | 1,701,276 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2023-06-13 | M | A | 7,927 | $2.25 | 1,709,203 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-15 | S | D | 12,773 | $16.13 | 1,701,276 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 4 | Common | Common Stock | 2023-06-15 | M | A | 12,773 | $2.25 | 1,714,049 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-06-13 | M | D | 7,927 | $0.00 | 389,610 | D | $2.25 · — to 2031-03-09 | 7,927 Common Stock | (F4) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-06-15 | M | D | 12,773 | $0.00 | 376,837 | D | $2.25 · — to 2031-03-09 | 12,773 Common Stock | (F4) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |